TGTX FY 2019 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TGTXTG Therapeutics, Inc.

$5B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$152,000+0.0% YoY

Gross Profit

$152,000100.0% margin

Operating Income

-$169M-111220.4% margin

Net Income

-$173M-113730.9% margin

EPS (Diluted)

$-1.96

Cash Flow

Operating Cash Flow

-$133M

Free Cash Flow

-$133M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$163M

Total Liabilities

$124M

Stockholders' Equity

$39M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$152,000	$152,000	+0.0%
Gross Profit	$152,000	$64,000	+137.5%
Operating Income	-$169M	-$174M	+3.1%
Net Income	-$173M	-$173M	+0.4%